Following is our
new address and
phone number:


Tamir Biotechnology, Inc.
12625 High Bluff Dr.
Suite 113
San Diego, CA 
92130

732 823-1003

 





April 10, 2014
To our valued shareholders,

On September 10, 2013, Tamir Biotechnology, Inc. (“Tamir” or the “Company”), formerly called Alfacell Corporation, completed a 1-for-100 reverse stock split approved by its stockholders (the “Reverse Stock Split”). As a result of the Reverse Stock Split, for each 100 shares of Tamir’s Common Stock you held on the record date you now have 1 share of Common Stock after the reverse split. In March, 2014 our Transfer agent Direct Transfer LLC sent out the letter of transmittal to exchange your pre reverse split stock certificates. Please note that only shareholders who hold the certificates in their own names directly and not with brokers, custodians or other form of beneficial ownership will receive the letter. The exchange of all other shares will be coordinated between Direct Transfer and the Depository Trust Co. If you have any questions please contact the transfer agent at 919.481.4000.

January 30, 2014
Notice to Stockholders

February 5, 2014
In May of 2013, Tamir received a decision from the SEC, revoking registration of the common stock of Tamir. Broker-dealers have been prohibited from executing trades of Tamir common stock, and thus, public trading of Tamir's stock ceased in early July of 2013. Now, with a new management team in place, we are all dedicated to refocusing the science toward solving difficult antiviral problems (such as HPV and CMV). We believe in the potential efficacy of Onconase(r) for the treatment of viruses, so we continue work to obtain credible results.

January 30, 2014
Notice to Stockholders








© 1998-2014, Tamir Biotechnology, Inc., formerly Alfacell Corporation

Tamir Biotechnology, Inc.
12625 High Bluff Dr.
Suite 113
San Diego, CA 92130

732 823-1003
www.TamirBio.com
info@tamirbio.com
Disclaimer